Childhood brain tumor experts to advise PBTF
The PBTF’s new Research Advisory Network will help evaluate research funding priorities and guide investments.
The Pediatric Brain Tumor Foundation has invested more than $24 million in cutting-edge medical research to date. Now a new Research Advisory Network will contribute insights that help shape the PBTF’s funding priorities and evaluate the impact of its research investment on the lives of children diagnosed with a brain tumor, as well as on the disease that threatens them.
The 17 volunteer members of the panel are drawn from medical centers, a research institution, a brain tumor nonprofit and the pharmaceutical industry. They will serve a three-year, renewable term.
The experts are:
- Suzanne Baker, PhD, St. Jude Children’s Research Hospital
- Jill Barnholtz-Sloan, PhD, Case Western Reserve University
- Oren Becher, MD, Duke University School of Medicine
- Tom Curran, PhD, FRS, The Children’s Hospital of Philadelphia
- Yancey Gillespie, PhD, University of Alabama at Birmingham
- Gerald Grant, MD, Stanford School of Medicine
- Nalin Gupta, MD, PhD, UCSF Benioff Children’s Hospital
- Mark Kieran, MD, PhD, Dana-Farber Cancer Institute and Boston Children’s Hospital
- Duane Mitchell, MD, PhD, University of Florida
- Michelle Monje-Deisseroth, MD, PhD, Stanford School of Medicine
- Sabine Mueller, MD, PhD, UCSF Benioff Children’s Hospital
- Roger Packer, MD, Children’s National Health System
- Will Parsons, MD, PhD, Texas Children’s Hospital
- Raphael Rousseau, MD, PhD, Genentech
- James Rutka, MD, PhD, FRCSC, FACS, FAAP, Hospital for Sick Children
- Max Wallace, Accelerate Brain Cancer Cure
- Robert Wechsler-Reya, PhD, Sanford-Burnham Medical Research Institute
“The members of the Research Advisory Network, or RAN, will provide highly informed perspectives on the biomedical research enterprise,” said Dr. Joanne Salcido, vice president of research and family support. “It is an important facet of the PBTF’s partnership with the research community.”
“Last May we held our first annual collaborative conference for thought leaders from the pediatric brain tumor community to discuss hot topics in the field,” Salcido said. “The relationships formed at the Translating Discoveries to Cure the Kids meeting will guide our future research strategy and investments to help us level the playing field for children with brain tumors.”
The Research Advisory Network replaces the PBTF’s former Scientific Advisory Board, and is a key part of the organization’s new research funding programs. First on its agenda is the launch of the PBTF’s new Early Career Development Awards later this month.